Tetsuya Nosaka, MD, PhD
経歴
1985年三重大学医学部を卒業後、すぐに京都大学大学院に入学、ウイルス研究所 畑中正一教授の下でレトロウイルス学と分子生物学を学ぶ。この間、一年間、国内留学により三重大学第二内科（白川茂教授)で臨床血液学も学ぶ。1989年、京都大学医学博士、同年4月、畑中研の助手（助教）となる。1994年2月、京大休職で米国St Jude Children’s Research Hospital留学（James N. Ihle教授）。1995年、Seattleでのアメリカ血液学会で、当時DNAXにおられた北村俊雄博士と知り合いになり、その後、北村博士が東大でラボを主宰されるのを機に、スタッフに採用され、帰国。1996年12月、東京大学医科学研究所造血因子探索寄付研究部門助手（助教）、1999年11月より同寄付研究部門助教授（准教授）、2006年12月より三重大学大学院医学系研究科教授。専門は白血病の分子生物学、ベクター開発、ウイルス学。「ど基礎」から臨床まで興味の範囲が広いのは、畑中研で育ったことと無縁ではないと思われる。細胞内情報伝達機構の解析と、成功を信じて正攻法で臨む研究スタイルをIhle研で学び、レトロウイルスを使った遺伝子発現クローニングと研究展開のエッセンスを北村研で学んだ。上記の他にも多くの師匠に恵まれ、故北堅吉先生（元三重大学准教授）からは鋭い観察・洞察力の大切さ、本庶佑教授（2018年ノーベル賞）からはずばり本質に迫る単純明快性、Peter
C. Doherty教授（1996年ノーベル賞）からは既成概念に囚われない柔軟な思考を学んだ。幼き頃、天体望遠鏡を通して生で見た土星のリングの神秘的美しさに思わず息を呑んだような経験は誰しもあると思うが、そのような感動を忘れず、「美しい」研究を目指している。
研究業績
Original
Articles
1. Nosaka
T, Ohno H, Doi S, Fukuhara S, Miwa H, Kita K, Shirakawa S, Honjo T, Hatanaka M. Phenotypic conversion of
T-lymphoblastic lymphoma to acute biphenotypic
leukemia composed of lymphoblasts and myeloblasts: Molecular genetic evidence
of the same clonal origin. J Clin Invest 81: 1824-1828, 1988.
2. Siomi H, Shida H, Nam SH, Nosaka
T, Maki M, Hatanaka M. Sequence requirements for nucleolar localization of
human T cell leukemia virus type I pX protein, which
regulates viral RNA processing. Cell 55: 197-209, 1988.
3. Siomi H, Nosaka T, Saida T, Miwa H, Hinuma Y, Shirakawa S, Miyamoto N, Kondo T, Araki K, Ichimaru M, Miura AB, Hatanaka M. Two major subgroups of
HTLV-I in
4. Ohno T, Kanoh
T, Arita Y, Fujii H,
Kuribayashi K, Matsuda T, Horiguchi Y, Taniwaki M, Nosaka T,
Hatanaka M, Uchino H. Fulminant clonal expansion of large granular lymphocytes.
Characterization of their morphology, phenotype, genotype, and function. Cancer
62: 1918-1927, 1988.
5. Miwa H, Nosaka
T, Kita K, Ohno T, Matsuoka N, Shirakawa S, Arita
Y, Doi S, Nishikori M, Honjo T, Hatanaka M. Immunogenotypes of lymphoid malignancies; the rearrangement
of the T cell receptor b chain gene can occur before the g chain gene
rearrangement. Jpn J Cancer Res 79: 484-490, 1988.
6. Nosaka
T, Siomi H, Adachi Y, Ishibashi M, Kubota S, Maki
M, Hatanaka M. Nucleolar targeting signal of human T-cell leukemia virus type I
rex-encoded protein is essential for
cytoplasmic accumulation of unspliced viral mRNA.
Proc Natl Acad Sci
7. Nosaka
T, Kita K, Miwa H, Kawakami K, Ikeda T, Ohno T, Matsuoka N, Arita Y, Doi S, Nishikori M, Matsuda F, Lee KH, Shirakawa
S, Honjo T, Hatanaka M. Cross-lineage gene
rearrangements of human leukemic Ｂ-precursor
cells occur frequently with V-DJ rearrangements of IgH
genes. Blood 74: 361-368, 1989.
8. Kamesaki H,
Fukuhara S, Uchino H, Nosaka T. A new
hypothesis on the cellular origin of Reed-Sternberg and Hodgkin cells based on
the immunological and molecular genetic analysis of the KM-H2 line. Recent
Results in Cancer Res 117: 83-90, 1989.
9. Miwa H, Kita K, Nosaka
T, Kawakami K, Ikeda T, Shirakawa S. A mechanism for cross-lineage gene
rearrangements in B-cell neoplasm. Acta Haematol Jpn 52: 1442-1450, 1989.
10. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M. Oncogenic
transformation by the tax gene of
human T-cell leukemia virus type I in
vitro. Proc Natl Acad Sci
11. Kanamori H, Suzuki N, Siomi H, Nosaka T,
Sato A, Sabe H, Hatanaka M, Honjo T. HTLV-I p27rex
stabilizes human interleukin-2 receptor a-chain mRNA. EMBO J 9: 4161-4166,
1990.
12. Adachi Y, Nosaka
T, Hatanaka M. Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I
(HTLV-I). Biochem Biophys
Res Commun 169: 469-475, 1990.
13. Ikeda T, Kita K, Miwa H, Kawakami K, Anazawa H, Ohno T, Nosaka
T, Hatanaka M, Honjo T, Shirakawa S. Genetic
heterogeneity in blast crisis of chronic myelocytic leukemia. Leukemia Res 14:
195-201, 1990.
14. Arita Y,
Kita K, Nasu K, Doi S, Fukuhara S, Nishikori M, Miwa
H, Tatsumi E, Nosaka T, Hatanaka M,
Uchino H. Frequent expression of myeloid antigen (CD13) on immature T cells in
culture. Acta Haematol Jpn
53: 21-34, 1990.
15. Kubota S, Nosaka
T, Cullen BR, Maki M, Hatanaka M. Effects of chimeric mutants of human
immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex on
nucleolar targeting signals. J Virol 65: 2452-2456,
1991.
16. White KN, Nosaka
T, Kanamori H, Hatanka M, Honjo
T. The nucleolar localisation signal of the HTLV-I
protein p27rex is important for stabilisation of IL-2
receptor a subunit mRNA by
p27rex. Biochem Biophys Res
Commun 175: 98-103, 1991.
17. Kubota S, Nosaka
T, Furuta R, Maki M, Hatanaka M. Functional
conversion from HIV-1 Rev to HTLV-1 Rex by mutation. Biochem
Biophys Res Commun 178:
1226-1232, 1991.
18. Hatabu H, Kasagi K, Iida Y, Nosaka
T, Misaki T, Hidaka A, Tokuda Y, Endo K, Mori T,
Lee K, Tsuboi K, Hatanaka M, Konishi
J. Induction of c-fos and c-myc
mRNA expression by immunoglobulin G from patients with Graves’ disease in thyrotrophin-dependent rat
thyroid cell line (FRTL5). Clin Endocrinol 34: 349-356, 1991.
19. Adachi Y, Copeland TD, Takahashi C, Nosaka T, Ahmed A, Oroszlan
S, Hatanaka M. Phosphorylation of the Rex protein of human T-cell leukemia
virus type I. J Biol Chem 267: 21977-21981, 1992.
20. Sakurai M, Yamaoka S, Nosaka T, Akayama
M, Tanaka A, Maki M, Hatanaka M. Transforming activity and the level of Tax
protein: Effect of one point mutation in HTLV-I tax gene. Int J Cancer 52: 323-328, 1992.
21. Miyazaki Y, Takamatsu T, Nosaka T, Fujita S, Hatanaka M. Intranuclear
topological distribution of HIV-1 trans-activators. FEBS Lett 305: 1-5, 1992.
22. Miwa H, Kita K, Nosaka
T, Ikeda T, Kawakami K, Anazawa H, Hoshino K, Ohno
T, Honjo T, Hatanaka M, Shirakawa S. Maturational
stage specific immunoglobulin heavy chain gene rearrangements, determined by D
and D upstream region gene structures. Leukemia Res 16: 861-871, 1992.
23. Kawakami K, Kita K, Miwa H, Ikeda T,
Nishii K, Masuya M, Morita N, Ohno T, Tanaka I, Nosaka T, Honjo T,
Shirakawa S. Rearrangement patterns of immunoglobulin heavy chain (IgH) and light chain genes in acute lymphoblastic leukemia
and chronic myelocytic leukemia lymphoid crisis cells showing oligoclonal IgH gene rearrangements. Int J Hematol
55: 61-69, 1992.
24. Nosaka
T, Takamatsu T, Miyazaki Y, Sano K, Sato A, Kubota S, Sakurai M, Ariumi Y, Nakai M, Fujita S,
Hatanaka M. Cytotoxic activity of rev protein
of human immunodeficiency virus type 1 by nucleolar dysfunction. Exp Cell Res
209: 89-102, 1993.
25. Nosaka
T, Ariumi Y, Sakurai M, Takeuchi R, Hatanaka M.
Novel internal promoter/enhancer of HTLV-I for Tax expression. Nucl Acids Res 21: 5124-5129, 1993.
26. Nakajima T, Aono
H, Hasunuma T, Yamamoto K, Maruyama I, Nosaka T, Hatanaka M, Nishioka
K. Overgrowth of human synovial cells driven by the human T cell leukemia virus
type I tax gene. J Clin Invest 92:
186-193, 1993.
27. Takano E, Nosaka
T, Lee WJ, Nakamura K, Takahashi T, Funaki M, Okada H, Hatanaka M, Maki M.
Molecular diversity of calpastatin in human erythroid
cells. Arch Biochem Biophys
303: 349-354, 1993.
28. Tanabe S, Fukuhara S, Yoneda T, Ohmori K, Nosaka T, Hatanaka M, Okuma M.
Characterization of a novel biphenotypic leukemia
cell line, TA-1, with myeloperoxidase and inducible cytoplasmic m chain:
Altered rearrangement patterns of antigen receptor genes. Int J Hematol 57: 229-243, 1993.
29. Ueba T, Nosaka T, Takahashi JA, Shibata F, Florkiewicz RZ, Vogelstein B, Oda Y, Kikuchi H, Hatanaka M.
Transcriptional regulation of basic fibroblast growth factor gene by p53 in
human glioblastoma and hepatocellular carcinoma cells. Proc Natl Acad Sci
30. Nosaka
T, Miyazaki Y, Takamatsu T, Sano K, Nakai M,
Fujita S, Martin TE, Hatanaka M. The post-transcriptional regulator Rex of the
human T-cell leukemia virus type I is present as nucleolar speckles in infected
cells. Exp Cell Res 219: 122-129, 1995.
31.
32. Nosaka
T, van Deursen JMA, Tripp RA, Thierfelder
WE, Witthuhn BA, McMickle
AP, Doherty PC, Grosveld GC, Ihle
JN. Defective lymphoid development in mice lacking JAK3. Science 270: 800-802,
1995.
33. Quelle FW, Wang D, Nosaka
T, Thierfelder WE, Stravopodis
D, Weinstein Y, Ihle JN. Erythropoietin induces activation
of Stat5 through association with specific tyrosines
on the receptor that are not required for a mitogenic response. Mol Cell Biol
16: 1622-1631, 1996.
34. Shimoda K,
van Deursen J, Sangster MY, Sarawar
SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka
T, Vignali DAA, Doherty PC, Grosveld
G, Paul WE, Ihle JN. Lack of interleukin-4-induced
Th2 response and IgE class switching in mice with
disrupted Stat6 gene. Nature 380: 630-633, 1996.
35.
36. Ariumi Y,
Copeland TD, Nosaka T, Hatanaka M.
HIRF: a novel nuclear factor that binds to the human T-cell leukemia virus type
I internal regulatory element (HIRE). Leukemia 11 Suppl 3: 29-31, 1997.
37. Sohn SJ, Forbush
KA, Nguyen N, Witthuhn B, Nosaka
T, Ihle JN, Perlmutter RM. Requirement for Jak3
in mature T-cells: Its role in regulation of T cell homeostasis. J Immunol 160:
2130-2138, 1998.
38. Onishi M, Nosaka T, Misawa K, Mui ALF, Gorman D,
McMahon M, Miyajima A, Kitamura T. Identification and
characterization of a constitutively active STAT5 mutant that promotes cell
proliferation. Mol Cell Biol 18: 3871-3879, 1998.
39. Morikawa Y, Nishida H, Misawa K, Nosaka T, Miyajima
A, Senba E, Kitamura T. Induction of synaptosomal-associated
protein-23 kd (SNAP-23) by various cytokines. Blood
92: 129-135, 1998.
40. Habu K, Nakayama-Yamada J, Asano M, Saijo S, Itagaki K, Horai R, Yamamoto H, Sekiguchi T, Nosaka
T, Hatanaka M, Iwakura Y. The human T cell
leukemia virus type I-tax gene is
responsible for the development of both inflammatory polyarthropathy
resembling rheumatoid arthritis and noninflammatory ankylotic arthropathy in
transgenic mice. J Immunol 162: 2956-2963, 1999.
41. Brown MP*, Nosaka
T*, Tripp RA, Brooks J, van Deursen JMA, Brenner
MK, Doherty PC, Ihle JN. Reconstitution of early
lymphoid proliferation and immune function in Jak3-deficient mice by
interleukin-3. Blood 94: 1906-1914,
1999 (*Equal first authors).
42. Nosaka
T, Kawashima T, Misawa K, Ikuta K, Mui AL-F, Kitamura T. STAT5 as a
molecular regulator of proliferation, differentiation and apoptosis in
hematopoietic cells. EMBO J 18: 4754-4765, 1999.
43. Yamada K, Ariyoshi K, Onishi M, Miyajima A, Hayakawa F,
Towatari M, Saito H, Oka Y, Asano S, Nosaka T, Kitamura T. Constitutively active
STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a
frequent cause of leukemogenesis. Int J Hematol 71:
46-54, 2000.
44. Fujio K, Nosaka
T, Kojima T, Kawashima T, Yahara T, Copeland NG,
Gilbert DJ, Jenkins NA, Yamamoto K, Nishimura T, Kitamura T. Molecular cloning
of a novel type I cytokine receptor similar to the common gamma chain. Blood
95: 2204-2211, 2000.
45. Misawa K, Nosaka
T, Morita S, Kaneko A, Nakahata T, Asano S,
Kitamura T. A method to identify
cDNAs based on localization of green fluorescent protein fusion products. Proc
Natl Acad Sci USA 97: 3062-3066, 2000.
46. Ariyoshi K, Nosaka
T, Yamada K, Onishi M, Oka Y, Miyajima
A, Kitamura T. Constitutive activation of STAT5 by a point mutation in the SH2
domain. J Biol Chem 275;
24407-24413, 2000.
47. Misawa K, Nosaka
T, Kojima T, Hirai M, Kitamura T. Molecular cloning and characterization of
a mouse homolog of human TNFSF14, a member of the TNF superfamily. Cytogenet Cell Genet 89: 89-91, 2000.
48. Kawashima T, Hirose K, Satoh T, Kaneko
A, Ikeda Y, Kaziro Y, Nosaka
T, Kitamura T. MgcRacGAP is involved in the
control of growth and differentiation of hematopoietic cells. Blood 96:
2116-2124, 2000.
49. Fujio
K, Misaki Y, Setoguchi K, Morita S, Kawahata K, Kato
I, Nosaka T, Yamamoto K, Kitamura T.
Functional reconstitution of class II MHC-restricted T cell immunity mediated
by retroviral transfer of the ab TCR complex. J Immunol 165: 528-532, 2000.
50.
Sugiyama T, Kumagai H, Morikawa Y, Wada Y, Sugiyama
A, Yasuda K, Yokoi N, Tamura S, Kojima T, Nosaka
T, Senba E, Kimura S, Kadowaki
T, Kodama T, Kitamura T. A novel low-density lipoprotein receptor-related
protein mediating cellular uptake of apolipoprotein E-enriched b-VLDL in vitro. Biochemistry 39: 15817-15825,
2000.
51.
Hirose K, Kawashima T, Iwamoto I, Nosaka T,
Kitamura T. MgcRacGAP is
involved in cytokinesis through associating with mitotic spindle and
midbody. J Biol Chem 276:
5821-5828, 2001.
52.
Kawashima T, Murata K, Akira S, Tonozuka Y, Minoshima Y, Feng S, Kumagai H, Tsuruga H, Ikeda Y, Asano S, Nosaka
T, Kitamura T. STAT5 induces macrophage differentiation of M1 leukemia
cells through activation of IL-6 production mediated by NF-kB p65. J Immunol
167: 3652-3660, 2001.
53. Tonozuka Y, Fujio K, Sugiyama T, Nosaka
T, Hirai M, Kitamura T. Molecular cloning of a human novel type I cytokine
receptor related to d1/TSLPR. Cytogenet Cell Genet
93: 23-25, 2001.
54. Tulin EE, Onoda N, Maeda M, Hasegawa M, Nosaka
T, Nomura H, Asano S, Kitamura T. A novel secreted form of immune
suppressor factor with high homology to vacuolar ATPases identified by a
forward genetic approach of functional screening based on cell proliferation. J
Biol Chem 276: 27519-27526, 2001.
55. Tulin EE, Onoda N, Hasegawa M, Nosaka
T, Nomura H, Kitamura T. Genetic approach and phenotype-based
complementation screening for identification of stromal cell-derived proteins
involved in cell proliferation. Exp Cell Res 272: 23-31, 2002.
56. Nosaka T, Kitamuta
T. Pim-1 expression is sufficient to induce cytokine independence in murine
hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation.
Exp Hematol 30: 697-702, 2002.
57.
Nosaka T, Morita S, Kitamura H,
Nakajima H, Shibata F, Morikawa Y, Kataoka Y, Ebihara
Y, Kawashima T, Itoh T, Ozaki K, Senba E, Tsuji K, Makishima F, Yoshida N, Kitamura T. Mammalian Twisted
gastrulation is essential for skeleto-lymphogenesis.
Mol Cell Biol 23: 2969-2980, 2003.
58. Minoshima Y,
Kawashima T, Hirose K, Tonozuka Y, Kawajiri A, Bao YC, Deng X, Tatsuka
M, Narumiya S, May WS Jr, Nosaka
T, Semba K, Inoue T, Satoh T, Inagaki M, Kitamura T. Phosphorylation by
Aurora B converts MgcRacGAP to a RhoGAP
during cytokinesis. Dev Cell 4: 549-560, 2003.
59.
Murata K, Kumagai H, Kawashima T, Tamitsu
K, Irie M, Nakajima H, Suzu
S, Shibuya M, Kamihira S, Nosaka
T, Asano S, Kitamura T. Selective cytotoxic mechanism of GTP-14564, a novel
tyrosine kinase inhibitor in leukemia cells expressing a constitutively active Fms-like tyrosine kinase 3 (FLT3). J Biol Chem 278:
32892-32898, 2003.
60. Ikeda
Y, Imai Y, Kumagai H, Nosaka
T, Morikawa Y, Hisaoka T, Manabe I, Maemura K, Nakaoka T, Imamura T,
Miyazono K, Komuro I, Nagai R, Kitamura T. Vasorin, a transforming growth factor b-binding protein
expressed in vascular smooth muscle cells, modulates the arterial response to
injury in vivo. Proc Natl Acad
Sci
61. Tonozuka Y, Minoshima Y, Bao YC,
Moon Y, Tsubono Y, Hatori
T, Nakajima H, Nosaka T, Kawashima T,
Kitamura T. A GTPase-activating protein binds STAT3 and is required for
IL-6-induced STAT3 activation and for differentiation of a leukemic cell line.
Blood 104: 3550-3557, 2004.
62. Ono
R, Nakajima H, Ozaki K, Kumagai H, Kawashima T, Taki
T, Kitamura T, Hayashi Y, Nosaka T.
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce
multiple lineage leukemogenesis. J Clin Invest 115: 919-929, 2005.
63. Urano A, Endoh M, Wada T,
Morikawa Y, Itoh M, Kataoka Y, Taki T, Akazawa H, Nakajima
H, Komuro I, Yoshida N, Hayashi Y, Handa H, Kitamura T, Nosaka
T. Infertility with defective spermiogenesis in mice lacking AF5q31, the
target of chromosomal translocation in human infant leukemia. Mol Cell Biol 25:
6834-6845, 2005.
64. Ono R, Ihara M, Nakajima H, Ozaki K,
Kataoka-Fujiwara Y, Taki T, Nagata K, Inagaki M, Yoshida N, Kitamura T, Hayashi
Y, Kinoshita M, Nosaka
T. Disruption of Sept6, a fusion partner gene of MLL,
does not affect ontogeny, leukemogenesis induced by MLL-SEPT6, or phenotype induced by the loss of Sept4. Mol
Cell Biol 25: 10965-10978, 2005.
65. Ozaki K, Hishiya
A, Hatanaka K, Nakajima H, Wang G, Hwu P, Kitamura T,
Ozawa K, Leonard WJ, Nosaka T. Overexpression
of Interleukin 21 induces expansion of hematopoietic progenitor cells. Int J Hematol 84: 224-230, 2006.
66. Kawashima T, Bao YC, Moon Y, Tonozuka Y, Minoshima Y, Hatori T, Kiyono M, Nosaka T, Nakajima H, Williams DA, Kitamura
T. Rac 1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT
transcription factors. J Cell Biol 175: 937-946, 2006.
67. Lu Y, Kitaura
J, Oki T, Komeno Y, Ozaki K, Kiyono M, Kumagai H, Nakajima H, Nosaka
T, Aburatani H, Kitamura T. Identification of TSC-22 as a potential tumor
suppressor that is upregulated by Flt3-D835V but not Flt3-ITD. Leukemia 21:
2246-2257, 2007.
68. Watanabe-Okochi
N, Kitaura J, Ono R, Harada H, Harada Y, Komeno Y,
Nakajima H, Nosaka T , Inaba T,
Kitamura T. AML1 mutations induced MDS and MDS/AML in a mouse BMT model. Blood
111: 4297-4308. 2008.
69. Nishio M, Ohtsuka J, Tsurudome M, Nosaka T, Kolakofsky
D. Human parainfluenza virus type 2 V protein inhibits genome replication by
binding to the L protein; a possible role in promoting viral fitness. J Virol 82:
6130-6138, 2008.
70. Hiwatari M, Ono
R, Taki T, Hishiya A, Ishii E, Kitamura T, Hayashi Y,
Nosaka T. Novel gain-of-function
mutation in the extracellular domain of the PDGFRA gene in infant acute
lymphoblastic leukemia with t(4;11)(q21;q23). Leukemia 22: 2279-2280, 2008.
71. Ikeya M, Nosaka T, Fukushima K, Kawada M, Furuta Y, Kitamura T, Sasai Y.
Twisted gastrulation mutation suppresses skeletal defect phenotypes in Crossveinless 2 mutant mice. Mech Dev 125: 832-842, 2008.
72. Matsushita H, Nakajima H, Nakamura Y,
Tsukamoto H, Tanaka Y, Jin G, Yabe M, Asai S, Ono R, Nosaka T,
Sugita K, Morimoto A, Hayashi Y, Hotta T, Ando K,
Miyachi H. C/EBPa and C/EBPe
induce the monocytic differentiation of myelomonocytic cells with the
MLL-chimeric fusion gene. Oncogene 27: 6749-6760, 2008.
73. Kawashima T, Bao YC, Minoshima
Y, Nomura Y, Hatori T, Hori T, Fukagawa
T, Fukada T, Takahashi N, Nosaka
T, Inoue M, Sato T, Kukimoto-Niino M, Shirouzu,
M, Yokoyama S, Kitamura T. A Rac GTPase activating
protein MgcRacGAP is an NLS-containing nuclear
chaperone in the activation of STAT transcription factors. Mol Cell Biol 29:
1796-1813, 2009.
74. Watanabe-Okochi
N, Oki T, Komeno Y, Kato N, Yuji K, Ono R, Harada Y, Harada H, Hayashi Y,
Nakajima H, Nosaka T , Kitaura J, Kitamura T. Possible involvement of RasGRP4 in
leukemogenesis. Int J Hematol 89: 470-481, 2009.
75. Ono R, Kumagai
H, Nakajima H, Hishiya A, Taki T, Horikawa K, Takatsu
K, Satoh T, Hayashi Y, Kitamura T, Nosaka T .
Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce
acute leukemia through aberrant Hox expression and Raf activation. Leukemia 23: 2197-2209, 2009.
76. Jin G,
Matsushita H, AsaiS, Tsukamoto H, Ono R, Nosaka T , Yahata T, Takahashi S, Miyachi H.
FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1
expression. Biochem Biophys
Res Commun 390, 1001-1006, 2009.
77. Ikeya M,
Fukushima K, Kawada M, Onishi S, Furuta
Y, Yonemura S, Kitamura T, Nosaka
T, Sasai Y. Cv2, functioning as a pro-BMP factor
via twisted gastrulation, is required for early development of nephron
precursors. Dev Biol 337: 405-414, 2010.
78. Minobe K, Ono
R, Matsumine A, Shibata-Minoshima
F, Izawa K, Oki T, Kitaura J, Iino T, Takita J, Iwamoto S, Hori H, Komada
Y, Uchida A, Hayashi Y, Kitamura T, Nosaka
T. Expression of ADAMTS4 in Ewing’s sarcoma. Int J Oncol 37: 569-581, 2010.
79. Nishio M, Tsurudome M, Garcin D, Komada H, Ito M, Le Mercier P, Nosaka
T, Kolakofsky D. Human parainfluenza virus type 2
L protein regions required for interaction with other viral proteins and mRNA
capping. J Virol 85: 725-732, 2011.
80. Tsurudome M,
Ito M, Nishio M, Nakahashi
M, Kawano M, Komada H, Nosaka
T, Ito Y. Identification of domains on the fusion (F) protein trimer that
influence the hemagglutinin-neuraminidase specificity of the F protein in
mediating cell-cell fusion. J Virol 85: 3153-3161,
2011.
81. Suzuki K, Ono R, Ohishi
K, Masuya M, Kataoka I, Liu B, Nakamori Y, Ino K, Monma F, Hamada H,
Kitamura T, Katayama N, Nosaka T.
IKAROS isoform 6 enhances BCR-ABL1-mediated proliferation of human CD34+hematopoietic
cells on stromal cells. Int J Oncol 40: 53-62, 2012.
82. Komori T, Doi A, Nosaka
T, Furuta H, Akamizu T,
Kitamura T, Senba, E, Morikawa Y. Regulation of
AMP-activated Protein Kinase Signaling by AFF4, a Member of the AF4 (ALL1-fused
Gene from Chromosome 4) Family of Transcription Factors, in Hypothalamic
Neurons. J Biol Chem 287: 19985-19996, 2012.
83. Nagai Y, Iwade
Y, Hayakawa E, Nakano M,
84. Liu B, Ohishi
K, Orito Y, Nakamori Y, Nishikawa H, Ino K, Suzuki K, Matsumoto T, Masuya
M, Hamada H, Mineno J, Ono R, Nosaka
T , Shiku H, Katayama N. Manipulation of human
early T lymphopoiesis by coculture on human bone marrow stromal cells:
Potential utility for adoptive immunotherapy. Exp Hematol
41: 367-376, 2013.
85. Tsurudome M, Nakahashi M, Matsushima Y,Ito M, Nishio M, Kawano M, Komada H, Nosaka T. Full conversion of the hemagglutinin-neuraminidase
specificity of the parainfluenzavirus 5 fusion
protein by replacement of 21 amino acids in its head region with those of the
simian virus 41 fusion protein. J Virol 87:
8342-8350, 2013.
86. Ono R, Masuya
M, Nakajima H, Enomoto Y, Miyata E, Nakamura A, Ishii
S, Suzuki K, Shibata-Minoshima F, Katayama N,
Kitamura T, Nosaka T. Plzf drives MLL-fusion-mediated leukemogenesis specifically
in long term hematopoietic stem cells. Blood 122: 1271-1283, 2013.
87. Kitagawa H, Kawano M; Yamanaka K, Kakeda M, Tsuda K, Inada H, Yoneda
M, Sakaguchi T, Nigi A,
Nishimura K, Komada H, Tsurudome
M, Yasutomi Y, Nosaka
T , Mizutani H. Intranasally administered Antigen
85B gene vaccine in non-replicating human Parainfluenza type 2 virus vector
ameliorates mouse atopic dermatitis. PLoS One 2013
Jul 3; 8(7): e66614.
88. Hara K, Fukumura
M, Ohtsuka J, Kawano M, Nosaka
T. Human Parainfluenza virus type 2 vector induces dendritic cell
maturation without viral RNA replication/transcription. Hum Gene Ther 24: 683-691, 2013.
89. Shimozawa N,
Ono R, Shimada M, Shibata H, Takahashi I, Inada H, Takada T, Nosaka T, Yasutomi
Y. Cynomolgus monkey induced pluripotent stem cells established by using
exogenous genes derived from the same monkey species. Differentiation 85: 131-139,
2013.
90. Nagai Y, Iwade
Y, Hayakawa E, Nakano M, Sakai T, Mitarai S, Katayama M, Nosaka
T, Yamaguchi T. High resolution melting curve assay for rapid detection of
drug-resistant Mycobacterium tuberculosis. J Infect Chemother 19: 1116-1125,
2013.
91. Watanabe K, Matsubara A, Kawano M, Mizuno
S, Okamura T, Tsujimura Y, Inada H, Nosaka T, Matsuo K, Yasutomi
Y. Recombinant Ag85B vaccine by taking advantage of characteristics of human
parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses
by intranasal immunization. Vaccine 32: 1727–1735, 2014.
92. Ohtsuka J, Fukumura M, Tsurudome M, Hara K, Nishio M, Kawano M, Nosaka
T. Vero/BC-F: an efficient packaging cell line stably expressing F protein
to generate single round-infectious human parainfluenza virus type 2 vector.
Gene Ther 21:775-784, 2014.
93. Tsurudome M,
Ito M, Ohtsuka J, Hara K, Komada
H, Nishio M, Nosaka
T. The fusion protein specificity of the parainfluenza virus
hemagglutinin-neuraminidase protein is not solely defined by the primary
structure of its stalk domain. J Virol 89:
12374-12387, 2015.
94. Kitamura T, Okochi-Watanabe
N, Enomoto Y, Nakahara F, Oki T, Komeno Y, Kato N, Doki N, Uchida T, Kagiyama Y,
Togami K, Kawabata KC, Nishimura K, Hayashi Y, Nagase R, Saika
M, Fukushima T, Asada S, Fujino T, Izawa Y, Horikawa
S, Fukuyama T, Tanaka Y, Ono R, Goyama S, Nosaka T, Kitaura
J, Inoue D. Novel working hypothesis for pathogenesis of hematological
malignancies; Combination of mutations-induced cellular phenotypes determines
the disease (cMIP-DD). J Biochem
159: 17-25, 2016.
95. Kobayashi K, Yamaguchi M, Miyazaki K,
Imai H, Yokoe K, Ono R, Nosaka
T, Katayama N. Expressions of SH3BP5, LMO3, and SNAP25 in diffuse large
B-cell lymphoma cells and their association with clinical features. Cancer Med
5: 1802-1809, 2016.
96. Yamanaka K, Nakanishi T, Isono K, Hasegawa C, Inada Y, Mizutani
K, Matsushima Y, Okada K, Mabuchi T, Kondo M, Yamagiwa
A, Kakeda M, Habe K, Nosaka T, Gabazza
EC, Yamazaki H, Mizutani H, Kawano M. Restrictive interleukin-10 induction by an innocuous
Parainfluenza virus vector ameliorates nasal allergy. J Allergy Clin Immunol
139: 682-686.e7, 2017.
97. Takeuchi, T, Yamaguchi M, Kobayashi K,
Miyazaki K, Tawara I, Imai H, Ono R, Nosaka
T, Tanaka K, Katayama N. MYD88, CD79B, and CARD11 gene mutations in
CD5-positive diffuse large B-cell lymphoma. Cancer 123: 1166-1173, 2017.
98. Ono R. Masuya
M, Ishii S, Katayama N, Nosaka T. Eya2,
a target activated by Plzf, is critical for
PLZF-RARA-induced leukemogenesis. Mol Cell Biol 37:e00585-16, 2017.
99. Tsurudome M, Ohtsuka J, Ito M, Nishio M, Nosaka T. The hemagglutinin-neuraminidase
(HN) head domain and the fusion (F) protein stalk domain of the parainfluenza
viruses affect the specificity of the HN-F interaction. Front Microbiol 9: 391,
2018.
100. Nagatake T,
Suzuki H, Hirata S, Matsumoto N, Wada Y, Morimoto S, Nasu
A, Shimojou M, Kawano M, Ogami
K, Tsujimura Y, Kuroda E, Iijima
N, Hosomi K, Ishii KJ, Nosaka
T, Yasutomi Y, Kunisawa
J. Immunological association of inducible bronchus-associated lymphoid tissue
organogenesis in Ag85B-rHPIV2 vaccine-induced anti-tuberculosis mucosal immune
responses in mice. Int Immunol 30: 471-481, 2018.
101. Maharjan BD,
Ono R, Nosaka T. Eya2 is critical for
the E2A-HLF-mediated immortalization of mouse hematopoietic stem/progenitor
cells. Int J Oncol 54: 981-990, 2019.
102. Ohtsuka J,
Matsumoto Y, Ohta K, Fukumura
M, Tsurudome M, Nosaka
T, Nishio M. Nucleocytoplasmic shuttling of the
human parainfluenza virus type 2 phosphoprotein. Virology 528: 54-63, 2019.
103. Ohtsuka J, Fukumura M, Furuyama W, Wang S,
Hara K, Maeda M, Tsurudome M, Miyamoto H, Kaito A, Tsuda N, Kataoka Y, Mizoguchi A, Takada A, Nosaka T. A versatile platform technology for
recombinant vaccines using non-propagative human parainfluenza virus type 2
vector. Sci Rep 9: 12901, 2019.
104. D'Alessandro-Gabazza
CN, Kobayashi T, Yasuma T, Toda M, Kim H, Fujimoto H,
Hataji O, Takeshita A, Nishihama
K, Okano T, Okano Y, Nishii Y, Tomaru A, Fujiwara K,
D'Alessandro VF, Abdel-Hamid AM, Ren Y, Pereira GV, Wright CL, Hernandez A,
Fields CJ, Yau PM, Wang S, Mizoguchi A, Fukumura M, Ohtsuka J, Nosaka T, Kataoka K, Kondoh
Y, Wu J, Kawagishi H, Yano Y, Mackie RI, Cann I, Gabazza EC. A
Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary
fibrosis. Nat Commun 11:1539, 2020.
105. Sawaki A,
Miyazaki K, Yamaguchi M, Takeuchi T, Kobayashi K, Imai H, Tawara I, Ono R, Nosaka T, Katayama N. Genetic polymorphisms
and vincristine-induced peripheral neuropathy in patients treated with
rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
Int J Hematol 111: 686-691, 2020.
106. Ono R, Masuya
M, Inoue N, Shinmei M, Ishii S, Maegawa Y, Mahrjan BD, Katayama N, Nosaka
T. Tet1 is not required for
myeloid leukemogenesis by MLL-ENL in
novel mouse models. PLosONE 16(3): e0248425, 2021.
107. Ohtsuka J,
Imai M, Fukumura M, Maeda M, Eguchi
A, Ono R, Maemura T, Ito M, Yamayoshi
S, Kataoka Y, Kawaoka Y, Nosaka
T. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly
protects the upper and lower airways against SARS-CoV-2. iScience
24: 103379, 2021.
108. D'Alessandro-Gabazza
CN, Yasuma T, Kobayashi T, Toda M, Abdel-Hamid AM,
Fujimoto H, Hataji O, Nakahara H, Takeshita A, Nishihama K, Okano T, Saiki H, Okano Y, Tomaru
A, D'Alessandro VF, Shiraishi M, Mizoguchi A, Ono R, Ohtsuka J, Fukumura M, Nosaka T, Mi X, Shukla D, Kataoka K, Kondoh Y, Hirose M, Arai T, Inoue Y, Yano Y, Mackie RI, Cann I, Gabazza EC. Inhibition of
lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of
pulmonary fibrosis. Nat Commun 13: 1558, 2022.
109. Nakamura A, Masuya
M, Shinmei M, Tawara I, Nosaka T, Ono
R. Bahcc1 is critical for the
aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia. Blood Adv 8: 2193-2206, 2024.
110. Tharavecharak S, Fujimoto H, Yasuma T, D’Alessandro-Gabazza
CN, Toda M, Tomaru A, Saiki H, Uemura
M, Kogue Y, Ito T, Furuhashi
K, Okano T, Takeshita A, Nishihama K, Ono R, Hataji O, Nosaka T,
Kobayashi T, Gabazza, EC. Bleomycin-induced pulmonary
fibrosis in transgenic mice carrying the human MUC5B rs35705950 variant. Cells
13: 1523, 2024.
Book Chapters and Review Articles
1. Kita K, Miwa H, Nosaka
T, Ohno T, Nasu K, Nanba K, Shirakawa S.
Molecular genetic analysis of lymphoid malignancies. In: Hanaoka M et al., eds.
Lymphoid Malignancy, Immunocytology and Cytogenetics.
2. Ihle JN, Nosaka T, Thierfelder W, Quelle FW, Shimoda
K. Jaks and Stats in cytokine signaling. Stem Cells 15 Suppl 1: 105-112, 1997.
3. Onishi M, Nosaka T,
Kitamura T. Cytokine Receptors: Structure and signal transduction. Int Rev
Immunol 16: 617-634, 1998.
4. Nosaka
T, Onishi M, Kawashima T, Yamada K, Misawa K,
Ariyoshi K, Towatari M, Saito H, Tani
K, Asano S, Miyajima A, Kitamura T. Identification
and characterization of constitutively active STAT5. In: Abraham NG et al.,
eds. Molecular Biology of Hematopoiesis 6.
5. Nosaka
T, Kitamura T. Janus kinases (JAKs) and signal transducers and activators
of transcription (STATs) in
hematopoietic cells. Int J Hematol 71: 309-319, 2000.
6.
Kitamura T, Kawashima T, Minoshima Y, Tonozuka Y, Hirose K, Nosaka
T. Role of MgcRacGAP/Cyk4 as a regulator of the
small GTPase Rho family in cytokinesis and cell differentiation. Cell Struct Funct 26: 645-651, 2001.
7. Nosaka
T. Jaks and normal hematopoiesis. In: Ward AC ed. The Jak-Stat Pathway in
Hematopoiesis and Disease.
8.
Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, Kumagai
H. Retrovirus-mediated gene transfer and expression cloning: Powerful tools in
functional genomics. Exp Hematol 31: 1007-1014, 2003.
9. Ono R, Nosaka T, Hayashi Y. Roles of a trithorax group gene, MLL, in hematopoiesis. Int J Hematol 81: 288-293, 2005.
10. Nosaka T, Ohtsuka J, Ohtsuka T, Fukumura M. Next generation RNA/protein-carrying vector with pleiotropic activity. Rev Med Virol 34: e70008, 2024.
日本語論文、著書
1. 宇野伸郎、野阪哲哉、内山哲、川上恵基、星野賢一郎、森美貴、堀田安則、太田千鶴子、小林透、北堅吉、白川茂. 造血器悪性疾患に合併した重症感染症に対する Amikacin と Cefoxitin の併用療法. Jpn J Antibiotics 40(3): 469-475, 1987.
2. 三輪啓志、松岡信良、野阪哲哉、北堅吉、白川茂. 悪性リンパ腫診断における分子遺伝学的手法の有用性と限界. 日本網内系学会会誌 29(2): 127-135, 1989.
3. 野阪哲哉. 悪性リンパ腫の病因：ウイルス. Pharma
Medica 11(2): 15-19, 1993.
4. 野阪哲哉. アンチセンス、env、腫瘍壊死因子、DNA修飾酵素、リンフォトキシン. In: 永田和宏、長野敬、宮坂信之、宮坂昌之 編集. 分子生物学・免疫学キーワード辞典 東京 医学書院 pp27-28, 100, 231-232, 296, 482. 1994.
5. 宮崎之男、野阪哲哉、畑中正一. 第3章 蛍光顕微鏡モードによる応用、4. 細胞内構造の観察への応用、 5) 核小体とウイルス. In: 石川春律、高松哲郎 編集. 新しい光学顕微鏡 第二巻 共焦点レーザ顕微鏡の医学・生物学への応用 東京 学際企画 pp111-115, 1995.
6. 野阪哲哉. JAK3
欠損マウスとリンパ球. 血液・腫瘍科 34(1): 48-55, 1997.
7. 野阪哲哉. JAK3 と SCID. 医学のあゆみ 180(13): 842-845, 1997.
8. 野阪哲哉、北村俊雄.
STAT 遺伝子の変異と機能変化. 血液・腫瘍科 40(6): 541-550, 2000.
9. 野阪哲哉、北村俊雄. 造血疾患と転写因子. 組織培養工学 特集 転写因子の新しい展開 26(13): 503-506, 2000.
10. 野阪哲哉. アダプター蛋白、アンチセンスRNA、 アンチセンス鎖、アンチセンスDNA、アンチセンス法、修飾（DNAの）、DNAグリコシラーゼ. In: 伊藤正男、井村裕夫、高久史磨 編集. 医学大辞典 東京 医学書院 pp28, 81, 1111, 1682. 2003.
11. 野阪哲哉. アンチセンス、env、Grb2、JNK/p38カスケード、Sos (son of sevenless)、DNA修飾酵素、DNAリガーゼ. In: 永田和宏、宮坂昌之、宮坂信之、山本一彦 編集. 分子生物学・免疫学キーワード辞典 第2版 東京 医学書院 pp57-58, 206, 285, 417-418, 516, 555-556, 563.
2003.
12. 野阪哲哉. プロテアーゼと白血病発症の意外な関係. In: News & Hot Paper Digest. 実験医学 22(1): 43-44, 2004.
13. 北村俊雄、野阪哲哉. 新規チロシンキナーゼ阻害剤GTP14564とFlt3. マクロファージ フォーラム Mini-review In: 今日の移植. 17(3): 416-420, 2004.
14. 北村俊雄、熊谷英敏、野阪哲哉. Flt3阻害剤. In: 血液病の分子標的療法〜新たな展開〜. 血液フロンティア. 14(7):
47-53(1035-1041), 2004.
15. 小埜良一、野阪哲哉. MLL関連白血病の分子病態. 血液・腫瘍科 52(6): 615-624,
2006.
16. 野阪哲哉. 造血器腫瘍マウスモデル. がん分子標的治療.6(2):25-33(101-109),
2008.
17. 野阪哲哉 、小埜良一. MLL融合遺伝子による白血病発症機構. 血液・腫瘍科. 61(2): 217-223,
2010.
18. 野阪哲哉. 血液腫瘍モデル動物の現状と展望. In: 金倉譲 編集. 造血器腫瘍学-基礎と臨床の最新研究動向- 日本臨床2012年4月
増刊.
pp159-164.
19. 野阪哲哉. Jak-STAT経路. In: 栗原裕基 編集. 細胞シグナル操作法. 生体の科学 66: 420-421,
2015.
20. 福村 正之, 大塚 順平, 野阪 哲哉. 有効なワクチンのない感染症に対してstructure-based designに基づいた新規ワクチンの開発. In: バイオベンチャー企業の新展開. Journal of
Biological Macromolecules 18(2): 42, 2018.
21. 小埜良一、野阪哲哉. 血液腫瘍モデル動物の現状と展望. In: 金倉譲 編集. 造血器腫瘍学（第2版）-基礎と臨床の最新研究動向-. II. 造血器腫瘍の基礎日本臨床 78巻 増刊号3 (2020年8月31日発行)
pp152-158.
22. 野阪哲哉. 新型コロナウイルスに対する次世代型鼻スプレーワクチン開発. 脳と発達 54(Suppl）S89 2022年5月
23. 野阪哲哉、大塚順平、福村正之. 感染症における免疫学的検査と新規モダリティワクチン開発. 日本臨床検査医学会誌 72(6): 511-517,
2024.
所属学会
日本血液学会（平成12年より評議員、平成18年より20年まで編集委員）、日本癌学会、American
Society for Microbiology
学術上の栄誉
1989 年度 三医会賞
1995 年度 アメリカ血液学会賞（ASH Merit Award）
1996 年度 日本血液学会奨励賞
2006 年度 日本白血病研究基金 一般研究賞
2013 年度 日本白血病研究基金 一般研究賞
2024 年度 第3回 三重大学賞
